Setting a gold standard in meeting cannabis regulation

Medical Cannabis Network speaks with Bird & Bird’s Ben King and Sally Shorthose about the importance of product labelling and the regulation of medical cannabis.

Bird & Bird know that the issue of labelling medical cannabis products can be a confusing and challenging issue for new market entrants. It is important that the product be clearly classified as being either medicinal or recreational. The labelling of some products has been exploited, allowing them to be marketed as something they are not and undermining consumer confidence in the product.

 

Latest insights

More Insights
Crowds crossing lines 782x440

Poland: The draft amendment to the Special Act on Ukrainian Citizens in Poland is now available

3 minutes Apr 16 2024

Read More

International Employment UK-based team contributes to The Legal 500: Employment and Labour Law Comparative Guide

Apr 16 2024

Read More
Generative AI

China: Iwncomm v Apple - points to note in SEP licensing negotiation

Apr 16 2024

Read More